Interventional Radiology Devices
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Interventional Oncology Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Oncology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Ablation Devices
1.2.3 Embolization Devices
1.2.4 Support Devices
1.3 Market by Application
1.3.1 Global Interventional Oncology Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Bone Cancer
1.3.6 Breast Cancer
1.3.7 Prostate Cancer
1.3.8 Pancreatic Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Interventional Oncology Market Perspective (2017-2028)
2.2 Interventional Oncology Growth Trends by Region
2.2.1 Interventional Oncology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Interventional Oncology Historic Market Size by Region (2017-2022)
2.2.3 Interventional Oncology Forecasted Market Size by Region (2023-2028)
2.3 Interventional Oncology Market Dynamics
2.3.1 Interventional Oncology Industry Trends
2.3.2 Interventional Oncology Market Drivers
2.3.3 Interventional Oncology Market Challenges
2.3.4 Interventional Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Players by Revenue
3.1.1 Global Top Interventional Oncology Players by Revenue (2017-2022)
3.1.2 Global Interventional Oncology Revenue Market Share by Players (2017-2022)
3.2 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Oncology Revenue
3.4 Global Interventional Oncology Market Concentration Ratio
3.4.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2021
3.5 Interventional Oncology Key Players Head office and Area Served
3.6 Key Players Interventional Oncology Product Solution and Service
3.7 Date of Enter into Interventional Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Oncology Breakdown Data by Type
4.1 Global Interventional Oncology Historic Market Size by Type (2017-2022)
4.2 Global Interventional Oncology Forecasted Market Size by Type (2023-2028)
5 Interventional Oncology Breakdown Data by Application
5.1 Global Interventional Oncology Historic Market Size by Application (2017-2022)
5.2 Global Interventional Oncology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Interventional Oncology Market Size (2017-2028)
6.2 North America Interventional Oncology Market Size by Country (2017-2022)
6.3 North America Interventional Oncology Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Interventional Oncology Market Size (2017-2028)
7.2 Europe Interventional Oncology Market Size by Country (2017-2022)
7.3 Europe Interventional Oncology Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Market Size (2017-2028)
8.2 Asia-Pacific Interventional Oncology Market Size by Country (2017-2022)
8.3 Asia-Pacific Interventional Oncology Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Interventional Oncology Market Size (2017-2028)
9.2 Latin America Interventional Oncology Market Size by Country (2017-2022)
9.3 Latin America Interventional Oncology Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Market Size (2017-2028)
10.2 Middle East & Africa Interventional Oncology Market Size by Country (2017-2022)
10.3 Middle East & Africa Interventional Oncology Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Detail
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Interventional Oncology Introduction
11.1.4 Boston Scientific Revenue in Interventional Oncology Business (2017-2022)
11.1.5 Boston Scientific Recent Development
11.2 BTG
11.2.1 BTG Company Detail
11.2.2 BTG Business Overview
11.2.3 BTG Interventional Oncology Introduction
11.2.4 BTG Revenue in Interventional Oncology Business (2017-2022)
11.2.5 BTG Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Interventional Oncology Introduction
11.3.4 Medtronic Revenue in Interventional Oncology Business (2017-2022)
11.3.5 Medtronic Recent Development
11.4 Merit Medical
11.4.1 Merit Medical Company Detail
11.4.2 Merit Medical Business Overview
11.4.3 Merit Medical Interventional Oncology Introduction
11.4.4 Merit Medical Revenue in Interventional Oncology Business (2017-2022)
11.4.5 Merit Medical Recent Development
11.5 Terumo
11.5.1 Terumo Company Detail
11.5.2 Terumo Business Overview
11.5.3 Terumo Interventional Oncology Introduction
11.5.4 Terumo Revenue in Interventional Oncology Business (2017-2022)
11.5.5 Terumo Recent Development
11.6 Accuray
11.6.1 Accuray Company Detail
11.6.2 Accuray Business Overview
11.6.3 Accuray Interventional Oncology Introduction
11.6.4 Accuray Revenue in Interventional Oncology Business (2017-2022)
11.6.5 Accuray Recent Development
11.7 Alpinion Medical Systems
11.7.1 Alpinion Medical Systems Company Detail
11.7.2 Alpinion Medical Systems Business Overview
11.7.3 Alpinion Medical Systems Interventional Oncology Introduction
11.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2017-2022)
11.7.5 Alpinion Medical Systems Recent Development
11.8 Angiodynamics
11.8.1 Angiodynamics Company Detail
11.8.2 Angiodynamics Business Overview
11.8.3 Angiodynamics Interventional Oncology Introduction
11.8.4 Angiodynamics Revenue in Interventional Oncology Business (2017-2022)
11.8.5 Angiodynamics Recent Development
11.9 Atricure
11.9.1 Atricure Company Detail
11.9.2 Atricure Business Overview
11.9.3 Atricure Interventional Oncology Introduction
11.9.4 Atricure Revenue in Interventional Oncology Business (2017-2022)
11.9.5 Atricure Recent Development
11.10 Baylis Medical
11.10.1 Baylis Medical Company Detail
11.10.2 Baylis Medical Business Overview
11.10.3 Baylis Medical Interventional Oncology Introduction
11.10.4 Baylis Medical Revenue in Interventional Oncology Business (2017-2022)
11.10.5 Baylis Medical Recent Development
11.11 Bovie Medical
11.11.1 Bovie Medical Company Detail
11.11.2 Bovie Medical Business Overview
11.11.3 Bovie Medical Interventional Oncology Introduction
11.11.4 Bovie Medical Revenue in Interventional Oncology Business (2017-2022)
11.11.5 Bovie Medical Recent Development
11.12 Brainlab
11.12.1 Brainlab Company Detail
11.12.2 Brainlab Business Overview
11.12.3 Brainlab Interventional Oncology Introduction
11.12.4 Brainlab Revenue in Interventional Oncology Business (2017-2022)
11.12.5 Brainlab Recent Development
11.13 Bsd Medical
11.13.1 Bsd Medical Company Detail
11.13.2 Bsd Medical Business Overview
11.13.3 Bsd Medical Interventional Oncology Introduction
11.13.4 Bsd Medical Revenue in Interventional Oncology Business (2017-2022)
11.13.5 Bsd Medical Recent Development
11.14 C. R. Bard
11.14.1 C. R. Bard Company Detail
11.14.2 C. R. Bard Business Overview
11.14.3 C. R. Bard Interventional Oncology Introduction
11.14.4 C. R. Bard Revenue in Interventional Oncology Business (2017-2022)
11.14.5 C. R. Bard Recent Development
11.15 C2 Therapeutics
11.15.1 C2 Therapeutics Company Detail
11.15.2 C2 Therapeutics Business Overview
11.15.3 C2 Therapeutics Interventional Oncology Introduction
11.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2017-2022)
11.15.5 C2 Therapeutics Recent Development
11.16 Cardiofocus
11.16.1 Cardiofocus Company Detail
11.16.2 Cardiofocus Business Overview
11.16.3 Cardiofocus Interventional Oncology Introduction
11.16.4 Cardiofocus Revenue in Interventional Oncology Business (2017-2022)
11.16.5 Cardiofocus Recent Development
11.17 Cook Medical
11.17.1 Cook Medical Company Detail
11.17.2 Cook Medical Business Overview
11.17.3 Cook Medical Interventional Oncology Introduction
11.17.4 Cook Medical Revenue in Interventional Oncology Business (2017-2022)
11.17.5 Cook Medical Recent Development
11.18 Eckert And Ziegler Bebig
11.18.1 Eckert And Ziegler Bebig Company Detail
11.18.2 Eckert And Ziegler Bebig Business Overview
11.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
11.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2017-2022)
11.18.5 Eckert And Ziegler Bebig Recent Development
11.19 Edap Tms
11.19.1 Edap Tms Company Detail
11.19.2 Edap Tms Business Overview
11.19.3 Edap Tms Interventional Oncology Introduction
11.19.4 Edap Tms Revenue in Interventional Oncology Business (2017-2022)
11.19.5 Edap Tms Recent Development
11.20 Elekta
11.20.1 Elekta Company Detail
11.20.2 Elekta Business Overview
11.20.3 Elekta Interventional Oncology Introduction
11.20.4 Elekta Revenue in Interventional Oncology Business (2017-2022)
11.20.5 Elekta Recent Development
11.21 Galil Medical
11.21.1 Galil Medical Company Detail
11.21.2 Galil Medical Business Overview
11.21.3 Galil Medical Interventional Oncology Introduction
11.21.4 Galil Medical Revenue in Interventional Oncology Business (2017-2022)
11.21.5 Galil Medical Recent Development
11.22 Healthtronics
11.22.1 Healthtronics Company Detail
11.22.2 Healthtronics Business Overview
11.22.3 Healthtronics Interventional Oncology Introduction
11.22.4 Healthtronics Revenue in Interventional Oncology Business (2017-2022)
11.22.5 Healthtronics Recent Development
11.23 Insightec
11.23.1 Insightec Company Detail
11.23.2 Insightec Business Overview
11.23.3 Insightec Interventional Oncology Introduction
11.23.4 Insightec Revenue in Interventional Oncology Business (2017-2022)
11.23.5 Insightec Recent Development
11.24 Medwaves
11.24.1 Medwaves Company Detail
11.24.2 Medwaves Business Overview
11.24.3 Medwaves Interventional Oncology Introduction
11.24.4 Medwaves Revenue in Interventional Oncology Business (2017-2022)
11.24.5 Medwaves Recent Development
11.25 Mermaid Medical
11.25.1 Mermaid Medical Company Detail
11.25.2 Mermaid Medical Business Overview
11.25.3 Mermaid Medical Interventional Oncology Introduction
11.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2017-2022)
11.25.5 Mermaid Medical Recent Development
11.26 Microsulis Medical
11.26.1 Microsulis Medical Company Detail
11.26.2 Microsulis Medical Business Overview
11.26.3 Microsulis Medical Interventional Oncology Introduction
11.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2017-2022)
11.26.5 Microsulis Medical Recent Development
11.27 Monteris Medical
11.27.1 Monteris Medical Company Detail
11.27.2 Monteris Medical Business Overview
11.27.3 Monteris Medical Interventional Oncology Introduction
11.27.4 Monteris Medical Revenue in Interventional Oncology Business (2017-2022)
11.27.5 Monteris Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Interventional Oncology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Ablation Devices
Table 3. Key Players of Embolization Devices
Table 4. Key Players of Support Devices
Table 5. Global Interventional Oncology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Interventional Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Interventional Oncology Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Interventional Oncology Market Share by Region (2017-2022)
Table 9. Global Interventional Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Interventional Oncology Market Share by Region (2023-2028)
Table 11. Interventional Oncology Market Trends
Table 12. Interventional Oncology Market Drivers
Table 13. Interventional Oncology Market Challenges
Table 14. Interventional Oncology Market Restraints
Table 15. Global Interventional Oncology Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Interventional Oncology Market Share by Players (2017-2022)
Table 17. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology as of 2021)
Table 18. Ranking of Global Top Interventional Oncology Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Interventional Oncology Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Interventional Oncology Product Solution and Service
Table 22. Date of Enter into Interventional Oncology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Interventional Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Interventional Oncology Revenue Market Share by Type (2017-2022)
Table 26. Global Interventional Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Interventional Oncology Revenue Market Share by Type (2023-2028)
Table 28. Global Interventional Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Interventional Oncology Revenue Market Share by Application (2017-2022)
Table 30. Global Interventional Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Interventional Oncology Revenue Market Share by Application (2023-2028)
Table 32. North America Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Interventional Oncology Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Interventional Oncology Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 42. Boston Scientific Company Detail
Table 43. Boston Scientific Business Overview
Table 44. Boston Scientific Interventional Oncology Product
Table 45. Boston Scientific Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 46. Boston Scientific Recent Development
Table 47. BTG Company Detail
Table 48. BTG Business Overview
Table 49. BTG Interventional Oncology Product
Table 50. BTG Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 51. BTG Recent Development
Table 52. Medtronic Company Detail
Table 53. Medtronic Business Overview
Table 54. Medtronic Interventional Oncology Product
Table 55. Medtronic Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 56. Medtronic Recent Development
Table 57. Merit Medical Company Detail
Table 58. Merit Medical Business Overview
Table 59. Merit Medical Interventional Oncology Product
Table 60. Merit Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 61. Merit Medical Recent Development
Table 62. Terumo Company Detail
Table 63. Terumo Business Overview
Table 64. Terumo Interventional Oncology Product
Table 65. Terumo Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 66. Terumo Recent Development
Table 67. Accuray Company Detail
Table 68. Accuray Business Overview
Table 69. Accuray Interventional Oncology Product
Table 70. Accuray Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 71. Accuray Recent Development
Table 72. Alpinion Medical Systems Company Detail
Table 73. Alpinion Medical Systems Business Overview
Table 74. Alpinion Medical Systems Interventional Oncology Product
Table 75. Alpinion Medical Systems Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 76. Alpinion Medical Systems Recent Development
Table 77. Angiodynamics Company Detail
Table 78. Angiodynamics Business Overview
Table 79. Angiodynamics Interventional Oncology Product
Table 80. Angiodynamics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 81. Angiodynamics Recent Development
Table 82. Atricure Company Detail
Table 83. Atricure Business Overview
Table 84. Atricure Interventional Oncology Product
Table 85. Atricure Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 86. Atricure Recent Development
Table 87. Baylis Medical Company Detail
Table 88. Baylis Medical Business Overview
Table 89. Baylis Medical Interventional Oncology Product
Table 90. Baylis Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 91. Baylis Medical Recent Development
Table 92. Bovie Medical Company Detail
Table 93. Bovie Medical Business Overview
Table 94. Bovie Medical Interventional OncologyProduct
Table 95. Bovie Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 96. Bovie Medical Recent Development
Table 97. Brainlab Company Detail
Table 98. Brainlab Business Overview
Table 99. Brainlab Interventional OncologyProduct
Table 100. Brainlab Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 101. Brainlab Recent Development
Table 102. Bsd Medical Company Detail
Table 103. Bsd Medical Business Overview
Table 104. Bsd Medical Interventional OncologyProduct
Table 105. Bsd Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 106. Bsd Medical Recent Development
Table 107. C. R. Bard Company Detail
Table 108. C. R. Bard Business Overview
Table 109. C. R. Bard Interventional OncologyProduct
Table 110. C. R. Bard Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 111. C. R. Bard Recent Development
Table 112. C2 Therapeutics Company Detail
Table 113. C2 Therapeutics Business Overview
Table 114. C2 Therapeutics Interventional OncologyProduct
Table 115. C2 Therapeutics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 116. C2 Therapeutics Recent Development
Table 117. Cardiofocus Company Detail
Table 118. Cardiofocus Business Overview
Table 119. Cardiofocus Interventional OncologyProduct
Table 120. Cardiofocus Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 121. Cardiofocus Recent Development
Table 122. Cook Medical Company Detail
Table 123. Cook Medical Business Overview
Table 124. Cook Medical Interventional OncologyProduct
Table 125. Cook Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 126. Cook Medical Recent Development
Table 127. Eckert And Ziegler Bebig Company Detail
Table 128. Eckert And Ziegler Bebig Business Overview
Table 129. Eckert And Ziegler Bebig Interventional OncologyProduct
Table 130. Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 131. Eckert And Ziegler Bebig Recent Development
Table 132. Edap Tms Company Detail
Table 133. Edap Tms Business Overview
Table 134. Edap Tms Interventional OncologyProduct
Table 135. Edap Tms Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 136. Edap Tms Recent Development
Table 137. Elekta Company Detail
Table 138. Elekta Business Overview
Table 139. Elekta Interventional OncologyProduct
Table 140. Elekta Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 141. Elekta Recent Development
Table 142. Galil Medical Company Detail
Table 143. Galil Medical Business Overview
Table 144. Galil Medical Interventional OncologyProduct
Table 145. Galil Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 146. Galil Medical Recent Development
Table 147. Healthtronics Company Detail
Table 148. Healthtronics Business Overview
Table 149. Healthtronics Interventional OncologyProduct
Table 150. Healthtronics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 151. Healthtronics Recent Development
Table 152. Insightec Company Detail
Table 153. Insightec Business Overview
Table 154. Insightec Interventional OncologyProduct
Table 155. Insightec Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 156. Insightec Recent Development
Table 157. Medwaves Company Detail
Table 158. Medwaves Business Overview
Table 159. Medwaves Interventional OncologyProduct
Table 160. Medwaves Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 161. Medwaves Recent Development
Table 162. Mermaid Medical Company Detail
Table 163. Mermaid Medical Business Overview
Table 164. Mermaid Medical Interventional OncologyProduct
Table 165. Mermaid Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 166. Mermaid Medical Recent Development
Table 167. Microsulis Medical Company Detail
Table 168. Microsulis Medical Business Overview
Table 169. Microsulis Medical Interventional OncologyProduct
Table 170. Microsulis Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 171. Microsulis Medical Recent Development
Table 172. Monteris Medical Company Detail
Table 173. Monteris Medical Business Overview
Table 174. Monteris Medical Interventional OncologyProduct
Table 175. Monteris Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
Table 176. Monteris Medical Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Oncology Market Share by Type: 2021 VS 2028
Figure 2. Ablation Devices Features
Figure 3. Embolization Devices Features
Figure 4. Support Devices Features
Figure 5. Global Interventional Oncology Market Share by Application in 2021 & 2028
Figure 6. Liver Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Kidney Cancer Case Studies
Figure 9. Bone Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Interventional Oncology Report Years Considered
Figure 14. Global Interventional Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Interventional Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Interventional Oncology Market Share by Region: 2021 VS 2028
Figure 17. Global Interventional Oncology Market Share by Players in 2021
Figure 18. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Interventional Oncology Revenue in 2021
Figure 20. North America Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Interventional Oncology Market Share by Country (2017-2028)
Figure 22. United States Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Interventional Oncology Market Share by Country (2017-2028)
Figure 26. Germany Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Interventional Oncology Market Share by Region (2017-2028)
Figure 34. China Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Interventional Oncology Market Share by Country (2017-2028)
Figure 42. Mexico Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Interventional Oncology Market Share by Country (2017-2028)
Figure 46. Turkey Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Boston Scientific Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 49. BTG Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 50. Medtronic Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 51. Merit Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 52. Terumo Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 53. Accuray Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 54. Alpinion Medical Systems Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 55. Angiodynamics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 56. Atricure Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 57. Baylis Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 58. Bovie Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 59. Brainlab Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 60. Bsd Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 61. C. R. Bard Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 62. C2 Therapeutics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 63. Cardiofocus Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 64. Cook Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 65. Eckert And Ziegler Bebig Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 66. Edap Tms Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 67. Elekta Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 68. Galil Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 69. Healthtronics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 70. Insightec Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 71. Medwaves Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 72. Mermaid Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 73. Microsulis Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 74. Monteris Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific BTG Medtronic Merit Medical Terumo Accuray Alpinion Medical Systems Angiodynamics Atricure Baylis Medical Bovie Medical Brainlab Bsd Medical C. R. Bard C2 Therapeutics Cardiofocus Cook Medical Eckert And Ziegler Bebig Edap Tms Elekta Galil Medical Healthtronics Insightec Medwaves Mermaid Medical Microsulis Medical Monteris Medical